2026 · 2nd Quarter (Apr 1 - June 30)

HEARTFLOW, INC.

Filed by HEARTFLOW, INC..

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 21, 2026
Income: Not reported
Expenses: $100,000.00
Registrant: HEARTFLOW, INC.
Client: HEARTFLOW, INC.
Filing UUID: 773afc75-4e49-4157-ae05-327df654df7d
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Issues related to physician payments; issues related to Medicare reimbursement; issues related to Medicare reimbursement of AI-enabled technology; Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717/H.R. 5343); Health Tech Investment Act (S. 1399/H.R. 6197); H.R. 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027, issues related to health care, generally.

Literal federal measure citations: S. 1717, H.R. 5343, S. 1399, H.R. 6197, H.R. 9260

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.